Introduction. Although protein phosphorylation was discovered in the 1950's when casein was found to be a covalently modified phosphoprotein (1), it was not until the classic work of Krebs and Fischer with phosphorylase kinase (PhosK) that protein phosphorylation was discovered to be a regulatory mechanism (2). Over the ensuing decades we now appreciate that this is one of the major regulatory mechanisms in biology and that the eukaryotic protein kinases (EPKs) constitute one of the largest families encoded for by the human genome (3). Understanding the structure, function, and regulation of these proteins remains as one of the great challenges of the signaling community, and the importance of this superfamily is underscored by their therapeutic importance as drug targets (4, 5). As we think about the enormous complexity of the EPKs, which includes not only large membrane-spanning protein kinases such as the epidermal growth factor receptor (EGFR) (6) and the insulin receptor (InsR) (7, 8), as well as giant scaffold protein such as Titan (9), but also the multi-component signaling complexes such as mTOR (10, 11), it is important to recognize and appreciate the highly dynamic nature of the EPKs. They have evolved from the eukaryotic-like kinases (ELKs) (12, 13) to be molecular switches that are transiently and dynamically regulated. Their substrates are proteins, not small molecules, and unlike metabolic enzymes such as hexokinase and pyruvate kinase, they have not evolved to be efficient catalysts. In many cases, like MAP kinases (MAPKs), PKCs, and the non-receptor tyrosine kinases, dynamic translocation is a critical feature of their regulation while in other cases such as the EGFR the kinase remains localized to the plasma membrane but can be internalized as an endocytotic vesicle with its accessory machinery creating a transient signaling organelle (14). What is clear from all of these EPKs, however, is that they have not evolved to be efficient catalysts; they have evolved to be dynamic and highly regulated molecular switches. Kinome (1959Kinome ( -1979. Cyclic AMP-dependent protein kinase (PKA) was the second regulatory protein kinase to be discovered nearly a decade after PhosK (15). It was originally found as a contaminant of PhosK, and because phosphorylase kinase was its substrate it was initially called phosphorylase kinase kinase. The concept of kinase cascades was also thus embedded in those first two kinases where one kinase activated another. PhosK is a large multi-subunit kinase (a 4 b 4 g 4 d 4 ) that is dedicated exclusively to the phosphorylation of a single Ser near the
Birth of the
C-terminus of glycogen phosphorylase (16).Unlike PhosK, there are many other targets for PKA in the liver, but the fundamental concept of kinase cascades was revealed by these first two protein kinases. With the purification of the PKA catalytic (C) subunit (15) and the subsequent discovery of the PKA regulatory (R) subunits (17)(18)(19), it was quickly renamed cAMP-dependent protein kinase. Cyclic GMP-de...